Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT00443196

NCT00443196
Completed Phase 3

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with ovarian cancer, fallopian tube cancer, or primary peritoneal cancer (a cancer affecting the lining of the abdomen).
  • You are newly diagnosed and have never had chemotherapy before, OR you have a cancer that has not responded well to treatment and have had no more than 2 rounds of standard chemotherapy.
  • You are any age.
  • Your tumor can be reached safely for a small tissue sample (biopsy) or fluid drainage, and you agree to this procedure.
  • Chemotherapy is considered a suitable treatment option for you.

Who may not be able to join:

  • You have brain tumors that are causing symptoms or are not well controlled, or your tumor cannot be safely accessed for a biopsy.
  • You have cancer that has spread to the membranes surrounding the brain or spinal cord.
  • Chemotherapy is not considered a medically appropriate option for you.
  • You are pregnant. If you could become pregnant, you must inform your doctor right away if you think you may have become pregnant during the study, as you would need to be withdrawn. This applies to any woman who has had periods and has not gone through menopause (no periods for more than 12 months in a row) or had surgery to prevent pregnancy — even if you use contraception (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status
Completed
Phase
Phase 3
Sponsor
Pierian Biosciences
Registry
clinicaltrials_gov
Start date
1 March 2006

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Complete Response, No Response

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov